Compare ACN & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACN | TMO |
|---|---|---|
| Founded | 1989 | 1956 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6B | 216.4B |
| IPO Year | N/A | N/A |
| Metric | ACN | TMO |
|---|---|---|
| Price | $286.17 | $607.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 19 |
| Target Price | $301.41 | ★ $637.78 |
| AVG Volume (30 Days) | ★ 4.0M | 1.9M |
| Earning Date | 12-18-2025 | 01-29-2026 |
| Dividend Yield | ★ 2.28% | 0.28% |
| EPS Growth | 1.33 | ★ 8.54 |
| EPS | 12.09 | ★ 17.32 |
| Revenue | ★ $70,725,557,000.00 | $43,736,000,000.00 |
| Revenue This Year | $7.07 | $4.33 |
| Revenue Next Year | $5.39 | $5.05 |
| P/E Ratio | ★ $23.68 | $35.73 |
| Revenue Growth | ★ 6.58 | 3.22 |
| 52 Week Low | $229.40 | $385.46 |
| 52 Week High | $398.35 | $629.87 |
| Indicator | ACN | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 64.64 | 55.48 |
| Support Level | $280.74 | $594.30 |
| Resistance Level | $291.09 | $629.87 |
| Average True Range (ATR) | 8.31 | 14.74 |
| MACD | 0.95 | 0.73 |
| Stochastic Oscillator | 87.04 | 59.66 |
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).